The metabolic syndrome is associated with reduced risk of prostate cancer

Aaron J. Tande, Elizabeth A. Platz, Aaron R. Folsom

Research output: Contribution to journalArticlepeer-review

110 Scopus citations

Abstract

Diabetes is associated with reduced risk of prostate cancer, but whether the metabolic syndrome is associated with prostate cancer is not established. The authors assessed this association in the Atherosclerosis Risk in Communities (ARIC) Study, comprising 6,429 men in four US communities initially with no history of cancer and aged 45-64 years. Metabolic syndrome and other risk factors were assessed in 1987-1989. Follow-up for prostate cancer incidence (n = 385 through 2000) was accomplished through cancer registry and hospital linkage. At baseline, 1,871 men (29.5%) had the metabolic syndrome. After the authors adjusted for other risk factors, men with the metabolic syndrome (≥3 components) were significantly less likely to develop prostate cancer (relative risk = 0.77, 95% confidence interval: 0.60, 0.98) than men without the metabolic syndrome. Diabetes was negatively associated with prostate cancer, although the confidence interval included 1 (relative risk = 0.73, 95% confidence interval: 0.51, 1.05). When diabetic participants were excluded, the inverse association between metabolic syndrome and prostate cancer incidence was slightly strengthened. In this study, the metabolic syndrome was associated with decreased prostate cancer incidence. The authors hypothesize that this finding reflects a decrease in bioavailable (free and albumin-bound) testosterone with the metabolic syndrome and a concomitant reduction in prostate cancer risk.

Original languageEnglish (US)
Pages (from-to)1094-1102
Number of pages9
JournalAmerican journal of epidemiology
Volume164
Issue number11
DOIs
StatePublished - Dec 2006

Bibliographical note

Funding Information:
This research was sponsored by National Cancer Institute grant R03-CA65473 and by National Heart, Lung, and Blood Institute contracts N01-HC–55015, 55016, 55018, 55019, 55020, 55021, and 55022. Aaron Tande was supported by a grant from the Minnesota Medical Foundation, Minneapolis, Minnesota. The funding agencies had no role in the preparation of this manuscript.

Keywords

  • Diabetes mellitus
  • Metabolic syndrome X
  • Prospective studies
  • Prostatic neoplasms

Fingerprint

Dive into the research topics of 'The metabolic syndrome is associated with reduced risk of prostate cancer'. Together they form a unique fingerprint.

Cite this